2010
DOI: 10.1016/j.jclinepi.2010.01.010
|View full text |Cite
|
Sign up to set email alerts
|

Assessing the impact of attrition in randomized controlled trials

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
89
2

Year Published

2010
2010
2021
2021

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 113 publications
(92 citation statements)
references
References 26 publications
1
89
2
Order By: Relevance
“…Many, if not most, RCTs suffer some element of attrition. In particular, trials that rely on selfcompleted outcome measures, often delivered by post, from patients can have high levels of attrition and a 20% loss to follow-up in such trials is not uncommon [2]. Consequently, it is crucial that attrition is kept to a minimum.…”
Section: Introductionmentioning
confidence: 99%
“…Many, if not most, RCTs suffer some element of attrition. In particular, trials that rely on selfcompleted outcome measures, often delivered by post, from patients can have high levels of attrition and a 20% loss to follow-up in such trials is not uncommon [2]. Consequently, it is crucial that attrition is kept to a minimum.…”
Section: Introductionmentioning
confidence: 99%
“…4,6 However, it is important to state that discontinuation rates may vary depending on the therapeutic area, investigational drug, inclusion/exclusion criteria, and patient characteristics. 6 Death was the predominant reason for discontinuation (39.6%), as reported by this analysis.…”
Section: Discussionmentioning
confidence: 99%
“…2 High patient attrition rates also pose a risk to the interpretation and validity of the intended research findings. [2][3][4] Furthermore, the cost to recruit a patient is significantly higher than to retain an existing patient in a clinical trial. 5 Reported patient attrition rates range from 15% to 40% of enrolled subjects depending on the therapeutic area, investigational drug, inclusion/exclusion criteria, and patient characteristics.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…With proper randomization any imbalances of known and unknown prognostic factors between treatment arms are attributed simply to chance. [1][2][3][4] In addition, implementation of blinding, where applicable, is likely to reduce performance, detection and attrition bias. There is empirical evidence that implementation of blinding is associated with improved adherence to the assigned interventions and reduced losses to follow-up compared to unblinded trials.…”
Section: Introductionmentioning
confidence: 99%